Early Results of New Therapy for Choroidal Melanoma Show Promise

Source: Healio, January 2018

WAILEA, Hawaii — The light-activated AU-011 agent represents the first potential new therapy for choroidal melanoma in many decades, according to a speaker here.
Overall, the 5-year metastatic rate for all [choroidal melanoma] tumors is about 35%, Jay S. Duker, MD, said at Retina 2018, and current treatment is “not benign.”
Plaque brachytherapy, in and of itself, has morbidity, and the radiation itself has visual consequences, Duker said.